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ABSTRACT
This paper explores the idea that spatial planning-triggered satellite industrial platform-type
concentrations may, over time, automatically gain the capacity to generate substantial agglomera-
tion economies and ultimately transform into entities capable of stimulating self-perpetuating
growth. Applying the lexicon of agglomeration theory, the idea is explored in the context of the
spatial dynamics of the pharmaceutical industry in Ireland. Spatial concentration indices indicate
a particularly high level of spatial concentration in one of the industry’s sub-sectors, namely, drug
substance production. Based on interview data and secondary sources, a detailed investigation of
the spatial dynamics of the Irish concentrations suggests that, while some agglomeration advan-
tages have emerged, they remain relatively limited and have played only a minor role in shaping
local industrial concentration. They aremainly of the urbanisation type, relating particularly to the
pooledmarket for workers. The evidence serves to show that the kind of spatial planning-triggered
satellite industrial platforms in late-developing economies do not automatically start generating
substantial agglomeration economies and crucial technological spillovers, not even after, as in the
case of the Cork pharmaceuticals concentration, nearly 40 years of existence.
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INTRODUCTION
The tendency of economic activity in general,
and industrial activity in particular, to concen-
trate in particular localities or regions has long
attracted the attention of economists and geog-
raphers. The debate over the forms and deter-
minants of such spatial concentration has
recently been reignited (see McCann 1995;
Martin 1999; Parr 2002; Phelps & Ozawa 2003;
Phelps 2008).
The formation of industrial concentrations is
normally characterised as a sequential process,
consisting of an initial formation stage and a
subsequent second stage of self-sustaining
growth and development (Carlsson 2006). It is
generally believed that agglomeration advan-
tages, including technological spillovers, are
an important driver of this second stage of
industrial concentration. Moreover, this self-
perpetuating expansion is often interpreted as
an automatic process, in the sense that it
requires limited government industrial policy
intervention. However, some commentators
point out that, in certain types of industrial
concentrations, agglomeration advantages may
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play only a limited role in the industrial con-
centration process and that not all agglomera-
tion factors are relevant in all concrete
instances of concentration (see McCann 1995;
Malmberg et al. 2000).
Governments have sought to build on this
logic and have utilised spatial planning as a tool
for creating this initial formation stage of indus-
trial concentration with the view of triggering
this automatic agglomeration process. One
example of such spatial planning-driven indus-
trial concentrations is the government-planned
concentration that Markusen (1996) categor-
ises as ‘satellite industrial platforms’. The term
‘satellite industrial platform’ refers to congrega-
tions of unconnected branch facilities of exter-
nally based multiplant firms, often planned by
national or regional governments as a way of
stimulating regional development. Markusen
(1996) and Park (1996) posit that such satellite
platforms may over time gain the capacity to
generate substantial agglomeration economies
and ultimately transform into entities capable
of self-perpetuating growth. However, they do
not elaborate on the conditions that facilitate
such a transition. Specifically, it is unclear
whether such agglomeration and transition
processes operate autonomously or whether a
transition requires more comprehensive inno-
vation and industrial policy intervention. This is
one of the questions that our analysis seeks to
address.
Applying the lexicon of agglomeration
theory, this paper conceptualises the develop-
ment over time of government-planned satellite
platform concentrations and investigates one
critical case. The proposition of this paper is
that spatial planning-driven industrial concen-
trations, such as satellite industrial platforms,
are, even over time, unlikely to automatically
gain the capacity to generate substantial
agglomeration economies and subsequently
transform into entities capable of stimulating
self-perpetuating growth. In such a scenario,
rather than merely constituting the initial
trigger for a concentration, it is government
spatial planning and general location factors,
and not agglomeration economies that remain
the most important driver behind observed
industrial concentrations. Particularly in late
developing countries and regions, which are
generally characterised by an underdeveloped
innovation infrastructure and low levels of
entrepreneurial activity, spatial planning poli-
cies alone are unlikely to instigate a transforma-
tion into self-perpetuating concentrations.
The proposition outlined above will be inves-
tigated via a study of the spatial dynamics of the
pharmaceutical industry in Ireland. The Cork
concentration was the earliest established satel-
lite platform-type pharmaceutical manufactur-
ing concentration worldwide, and is currently
one of the two largest concentrations of its
kind worldwide. It therefore usefully serves as
a critical case for testing this paper’s proposi-
tion regarding the role of agglomeration econ-
omies in the development of satellite platform
concentrations.
The paper begins with a conceptualisation of
agglomeration economies and the develop-
ment of government-planned concentration
over time using the lexicon of agglomeration
theory. This is followed by an outline of the
development of the pharmaceutical industry in
Ireland. The next section is methodological,
focusing, firstly, on data issues encountered in
the research and, second, on the spatial con-
centration measures utilised in the analysis.
The paper then proceeds with a description of
the spatial distribution of the industry. It will be
shown that the overall level of spatial concen-
tration of the industry is entirely due to the
spatial concentration of one of the sub-sectors –
themanufacture of drug substances. The paper
continues with a more detailed investigation of
the spatial dynamics of the drug substance sub-
sector, identifying the initial causes of spatial
concentration and the subsequent role of
agglomeration economies. The paper con-
cludes with a discussion of key findings and
offers policy relevant insights into the require-
ments for instigating the transformation of sat-
ellite platforms into self-perpetuating clusters.
GOVERNMENT-TRIGGERED
CONCENTRATION
AND AGGLOMERATION
The period since the mid-1980s has been char-
acterised by a renewed interest in spatial con-
centration and agglomeration involving an
increasingly diverse range of theoretical per-
spectives (Benneworth & Henry 2004). The
variety of approaches considered has instigated
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an intense debate regarding the forms and
determinants of spatial concentration and the
operative processes involved (see McCann
1995; Martin 1999; Parr 2002; Phelps & Ozawa
2003; Brown & Rigby 2010; Boschma & Fornahl
2011). Two important foci of this debate have
related to: (1) the specific agglomeration
factors that are responsible for particular
observed concentrations; and (2) the extent to
which agglomeration economies are respon-
sible for observed spatial concentrations of
industrial activity.
A discussion of the first of these foci benefits
from an overview of the range of possible
agglomeration advantages. Marshall’s original
contributions are still useful for grouping the
agglomeration advantages identified in recent
literature. His observations on the subject of
agglomeration (Marshall 1898, 1919, 1930)
tend to be summarised into a triad of external
economies – a pooled market for workers with
specialised skills, a growing number of increas-
ingly specialised input suppliers and techno-
logical spillovers.
The local pool of labour can provide an effi-
ciency gain for both workers and firms by maxi-
mising job-matching opportunities and thus
reducing search costs (Simpson 1992; Gordon
&McCann 2000), while the associated accumu-
lation of human capital can enhance both
labour skills (Arrow 1962) and firm productiv-
ity (Romer 1987; Scott 1988). The argument
regarding input relations is also based on neo-
classical concepts such as cost minimisation,
economies of scale, and the Smithian division
of labour. A localised industry can support
more suppliers, which increases the level of
specialisation and efficiency of the supply base,
which, in turn, presents an efficiency gain for
the customers (Harrison 1992). The actual
driver for geographical proximity between
firms is the desire to reduce the costs of trans-
actions across space (Krugman 1991).
The third advantage that is commonly dis-
tilled from Marshall’s work, technological spill-
overs, introduces a more dynamic perspective.
It involves knowledge externalities which result
from the concentration of (both vertically and
horizontally) related firms, facilitating pro-
cesses of learning and innovation in the locality
(Malmberg &Maskell 1997, 2002). Technologi-
cal spillovers are believed to be intensified
by informal rules, conventions and other
‘untraded interdependencies’ (Storper 1995).
They are partially independent of the degree of
intentional interaction, that is, they occur irre-
spective of the fact that companies intention-
ally interact (e.g. in the context of commercial
and collaborative relations). Knowledge tends
to become embedded in the local milieu
(Malmberg 1996). Unintentional interaction
(Oerlemans & Meeus 2005), as distinct
from intentional exchange, involves the acts
of observation and comparison by firms
(Malmberg & Maskell 2002).
Hoover (1937) further refined the theory of
agglomeration economies by dividing such
economies into two distinct types: localisation
and urbanisation economies. Localisation
economies, as identified by Marshall (1898),
are advantages that firms in a single industry
gain from being located in the same location
while urbanisation economies are advantages
gained by all firms, regardless of sector, from
being located together. Recently, Asheim et al.
(2011) has coined the concept of ‘related
variety’, which in a sense links localisation and
urbanisation economies. Here the advantages
that firms in an industry gain from being
located in the same location also benefit firms
in a set of related industries (as opposed to
firms in a single industry or all firms in the
region).
Contributors to the debate suggest that not
all agglomeration economies are operational in
all concrete situations of concentration. This
point is of particular relevance to concentra-
tions of foreign branch plants in late develop-
ing countries (McCann & Mudambi 2004;
Phelps 2008). Given the fact that in many con-
centrations most firms are observed to have
few local backward linkages, cost-reduction in
inter-firm transactions is no longer regarded
as being helpful in explaining concentration
(Phelps 1991; McCann 1995). Partly as a result
of this, the focus of analysis has shifted to
technological spillovers and related social, cul-
tural and institutional issues (Martin 1999;
Malmberg & Maskell 2002). The problem is
that such technological spillovers are difficult
to identify and measure. In the absence of cost-
reduction factors, spatial concentrations are
often assumed to be shaped by local spillovers,
the existence of which has not been established
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(McCann 1995; Malmberg & Maskell 2002;
Orsenigo 2006).
The second, related, debate concerns the
extent to which agglomeration economies are
responsible for the genesis and sustainable
growth of observed spatial concentrations. A
commonly accepted view is that agglomeration
economies are a pervasive force, reinforcing
concentration (Orsenigo 2006; Menzel et al.
2010). Echoing Marshall’s distinction between
causes and advantages of localisation (Marshall
1898), the rationale of some approaches to
understanding cluster formation is that the
emergence of a cluster can be traced to a his-
torical accident, leading to an initial concentra-
tion of firms. Once a certain threshold has been
reached, agglomeration economies in the form
of regional labour-market pooling, specialised
suppliers and knowledge spillovers will occur
(Menzel et al. 2010). In this tradition, after the
initial inception of the industrial concentra-
tion, its further expansion is presented as a
more or less automatic process that does not
require comprehensive industrial policy inter-
vention. By this we mean policies directly
addressing areas such as regional innovation
capacity and entrepreneurial activity, as
opposed to the more basic spatial planning
interventions.
Important causes for initial concentration
today are related to government industrial
spatial planning and related infrastructural
spending by state and local government
authorities/agencies. Some of this is mediated
through government’s role in the supply-side of
the market for industrial sites, which partly
determines the pattern of industrial location
(Van der Krabben & Boekema 1994; Louw et al.
2004). This role can take the form of promot-
ing the development of well-serviced industrial
sites at certain locations (e.g. through
financial/fiscal incentives or the direct provi-
sion of well-serviced industrial sites) and/or
that of blocking industrial activities from other
locations (physical planning and environmen-
tal regulations). Such developments are par-
ticularly likely to occur in sectors that are
characterised by large-scale manufacturing
plants requiring large and well-serviced indus-
trial sites.
One example of such spatial planning driven
industrial concentrations are the satellite
industrial platforms identified by Markusen
(1996). Here, the initial concentration of the
branch operations of multiplant firms is stimu-
lated by the cheap provision of industrial sites
and infrastructure, as a way of promoting
regional development. Markusen suggests that
these districts are not static but may, over time,
transform into other types of districts, includ-
ing Marshallian-type districts. Park (1996) dis-
cusses a transition from a satellite industrial
district into an ‘advanced satellite’ industrial
district and, potentially, to a ‘pioneering high-
technology’ industrial district. To the extent
that these transitions are deemed likely, they
are strongly linked to the role of agglo-
meration economies. For example Markusen
(1996, p. 305) suggests that ‘over time, districts
built around platforms may begin to host
growth of suppliers, oriented towards platform
tenants, and they may enjoy some increase in
local entrepreneurship because the platform
enhances the pool of skilled personnel’ (see
also Park 1996). However, little attention has
been paid to the conditions that facilitate such
a transition. This raises the question of whether
such agglomeration and transition processes
operate autonomously or whether a transition
requires more comprehensive innovation and
industrial policy intervention.
It has been pointed out that in many cases of
concentration, agglomeration economies may
only play a limited role in driving the concen-
tration process (see McCann 1995; Malmberg
et al. 2000). An analysis of agglomeration pro-
cesses must take account of the fact that there
are probably not many industrial concentra-
tions where agglomeration economies are
totally absent (Parr 2002). Notably, most indus-
trial concentrations in the vicinity of urban
areas are bound to benefit from at least some
level of urbanisation economies in the form of
educational institutions, labourmarket pooling
and infrastructure. However, these may have
little impact on the process of spatial concen-
tration or only act as ‘reinforcing agglomera-
tion economies’ (Parr 2002).
The proposition of this paper is that spatial
planning-driven industrial concentrations,
such as satellite industrial platforms, are, even
over time, unlikely to automatically gain the
capacity to generate substantial agglomeration
economies and ultimately transform into enti-
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ties capable of stimulating self-perpetuating
growth of the type associated with ‘advanced
satellite’ industrial districts or ‘pioneering
high-technology’ industrial districts. In such a
scenario, rather than merely constituting the
initial trigger for a concentration, government
spatial planning and general location factors,
rather than agglomeration economies, remain
the most important driver behind observed
industrial concentrations. A certain level of
agglomeration economies may spontaneously
emerge over time, mainly of the urbanisation
type, and largely attributable to the presence of
a local pool of labour, but their role in shaping
local/regional industrial concentration remain
at a much lower order of magnitude than
that of spatial planning-type government
intervention.
Substantial agglomeration economies and
crucial technological spillovers are particularly
unlikely to be generated in the case of sectors
that are characterised by vertically strongly inte-
grated production systems and in the context of
late developing countries, generally character-
ised by an underdeveloped research infrastruc-
ture and low levels of entrepreneurship.
The Irish pharmaceutical industry provides
an ideal case in which to test the proposition
outlined above. The industry in Ireland has
been spatially concentrated since its inception,
and the Cork concentration has been in exist-
ence for nearly 40 years. The concentration was
the earliest established satellite platform-type
drug substance manufacturing concentration
worldwide. It is the largest concentration of its
kind in Europe, and together with Puerto Rico
is among the two largest of its kind globally
(Vinnova 2008). The drug-substance sub-sector
of the pharmaceutical industry is a prime
example of a sector characterised by large-scale
manufacturing plants, high infrastructural and
utility requirements and increasingly strict envi-
ronmental regulations. The following section
explores the development of the Irish pharma-
ceutical industry in more detail.
THE PHARMACEUTICAL INDUSTRY
IN IRELAND
The value chain of the pharmaceutical industry
includes the following segments: discovery,
product development; process R&D, manufac-
turing, sales and marketing and corporate
functions. Process R&D is concerned with the
development of efficient manufacturing pro-
cesses at commercial scale. Manufacturing
encompasses the production of drug sub-
stances, other (non-drug substance) intermedi-
ate inputs, finished drug products and finished
diagnostic products. Drug substances (or active
pharmaceutical ingredients) are the most
important ingredients of a drug product, being
responsible for its pharmacological effect (Van
Egeraat 2010).
Until the 1960s there was virtually no phar-
maceutical industry in Ireland (Galvin 1998).
The increasing shift towards more outward-
looking economic policies (focused strongly on
the stimulation of exports through the attrac-
tion of inward investment) from the end of the
1950s led quickly to the first substantial invest-
ments by foreign companies, including a
handful of pharmaceutical companies, in the
1960s. The pharmaceutical industry in Ireland
really took off in the 1970s after the Industrial
Development Authority (IDA), the state agency
responsible for attracting inward investment
identified the fine chemicals industry (includ-
ing pharmaceuticals) as one of the target
sectors (Childs 1996). Pharmaceutical manu-
facturing employment grew strongly, from just
over 1,300 in 1972 to nearly 19,500 in 2003, by
which time pharmaceuticals had become one
of Ireland’s leading industrial sectors.
The absolute growth figures mask qualitative
changes in Ireland’s role in the global produc-
tion networks since about the mid-1980s,
raising the level of value creation (Van Egeraat
& Barry 2009). First, many production sites
were given the responsibility of higher-skilled
product launch activities. Second, some phar-
maceutical plants in Ireland obtained wider
product mandates to cover European and
global markets.
In relation to R&D functions, since the mid-
1980s pharmaceutical firms started to signifi-
cantly internationalise their R&D activities.
However, much of this internationalisation has
been spatially highly selective, tending to con-
centrate in a small number ‘innovation arenas’
or ‘megacentres’ such as Boston and San Fran-
cisco (Zeller 2004). Ireland’s role in the high
value generating drug discovery and product
development activities has remained very
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limited (Van Egeraat & Barry 2009). Since the
mid-1990s, Irish subsidiaries have begun to play
an increasing role in the global process R&D
function. In the period 2000–06, the number of
people involved in process R&D almost
doubled. However, even in this area, Ireland’s
involvement is concentrated in the (relatively)
lower value generating down-stream phases of
the cycle (Van Egeraat & Breathnach 2012).
Indigenous companies have played a rela-
tively insignificant role in the sector’s growth.
In 2003, foreign companies accounted for 93
per cent of total pharmaceuticals employment
and virtually all employment in the drug sub-
stance sub-sector. US companies represented
the largest group by far, accounting for nearly
half of all foreign companies, followed by com-
panies from the UK (12%), France (9%),
Germany (10%), Switzerland (6%) and Japan
(6%). Indigenous operations remained rela-
tively small with only seven indigenous compa-
nies employing more than 50 staff (see
Table 1).
DATA AND METHODOLOGY
The analysis of spatial concentration and its
drivers is based on both quantitative and
qualitative research exercises. The quantitative
exercise involved the computation of spatial
concentration indicators for the pharmaceuti-
cals industry from the annual Forfás Employ-
ment Survey of manufacturing operations in
Ireland. The survey is conducted at operations
level. An operation in the data set is generally a
separately incorporated unit of a firm or corpo-
ration. The survey provides, for each year from
1972 onwards, data on the location, employ-
ment and activity of each manufacturing
operation in Ireland. Activity is categorised
in the survey returns using the 4-digit NACE
classification.
The following activities were included in the
analysis: drug substances (part of NACE 2441),
drug products (NACE 2442), diagnostics (part
of NACE 2466 and part of NACE 3310) and
other intermediate chemicals (part of NACE
2441). A separate category was included for a
small number of operations that produced
both drug substances and drug products. The
final data set includes a total of 122 pharmaceu-
tical manufacturing operations, 95 of which
were in operation in 2003 – the last year for
which data are made available at the required
level of aggregation (Table 1).
This dataset was used to compute measures
of spatial concentration in the pharmaceutical
industry and its various sub-sectors. The geo-
graphic unit of analysis used was the adminis-
trative county, giving a total of 26 observation
units. The level of spatial concentration of an
industry can be analysed very basically by
inspecting the geographical distribution of
employment across spatial units. The propor-
tion of employment in the top region or top
two regions can function as a simplemeasure of
spatial concentration.
Many measures of geographical concentra-
tion aim to compare the geographic pattern of
employment or plants for one sector with the
pattern of an aggregate (for example, all indus-
try). Such measures are often interpreted as an
indication of the operation of localisation
economies. This paper uses the index proposed
Table 1. Number of operations and employees in pharmaceutical industry, 2003.
Foreign Indigenous Total
Operations Employees Operations Employees Operations Employees
Drug substance 30 6,379 1 26 31 6,405
Drug product 32 9,082 13 886 45 9,968
Both substance and
product.
5 1,772 1 20 6 1,792
Other Intermediates 2 109 2 58 4 167
Diagnostics 5 732 4 411 9 1,143
Total 74 18,074 21 1401 95 19,475
Source: Based on Forfás Employment Survey.
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by Maurel and Sedillot (1999) (henceforth
referred to as the MS index). The index, g,
controls for differences in industrial concentra-
tion (distribution of employment over the
plants in an industry) and provides a measure
of spatial concentration of an industry (sugges-
tive of localisation economies) beyond what
would be expected on the basis of industrial
concentration. The formula for the MS index
is:
γ = −
−
G H
H1
.
The first component, G, is a measure of raw
geographic concentration, where:
G
s x
x
i
i
M
i
i
M
i
i
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−
−
= =
=
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∑
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,
si is the proportion of sector employment
located in geographic area i and xi is the
proportion of aggregate industrial employ-
ment in area i. M denotes the number of
geographic areas.
The size distribution of plants is controlled
via the Herfindahl index1 of industrial concen-
tration (measured as the distribution of
employment across plants), where:
H z j
j
N
=
=
∑ 2
1
,
zj is the share of plant j in total sector
employment and N denotes the number of
plants in the sector. Maurel and Sedillot
(1999) adopt the following classification of
concentration levels: a low degree of con-
centration (g < 0.02); moderately concentrated
(0.02 < g < 0.05); very concentrated (g > 0.05).
The qualitative research involved semi-
structured, face-to-face, interviews with senior
staff at twelve major pharmaceutical plants. As
part of a larger research project, a total of 53
senior staff members were interviewed, includ-
ing 12 general managers, 12 materials manag-
ers, 12 personnel managers and managers of
R&D. Researcher-developed questions dealt
with the decision-making involved in selecting
the plants’ locations, the relevance of various
agglomeration factors in the decision-making
process. All interviews were recorded and fully
transcribed. All interviews were conducted at
the companies’ premises and typically lasted
one hour.
In addition to the company interviews, the
research included 12 interviews with current
and retired staff at relevant institutions, notably
the Industrial Development Agency (in the
Dublin head office as well as the Cork regional
office) and Cork County Council (within whose
boundaries one of the main concentrations of
pharmaceuticals plants is located). The qualita-
tive micro-level data and contextual informa-
tion derived from these interviews was used to
make logical deductions regarding the rel-
evance of the various agglomeration factors.
The combination of multiple company inter-
views, interviews with agencies and the quanti-
tative exercise provided complementary
methodologies that allowed for cross-
verification and triangulation. This combina-
tion of research methods was preferred over
social network analysis which has recently
grown in popularity. Apart from the fact that
the required data is not available, social
network analysis has serious limitations in rela-
tion to identifying actual knowledge spill-over
in spatial concentrations (Van Egeraat &
Curran 2013).
It is important to be cautious when it comes
to drawing conclusions from corporate inter-
views. This applies in particular to data on tech-
nological spillovers. A number of strategies
were applied to minimise the potential prob-
lems associated with corporate interviews
(Schoenberger 1991). In relation to the struc-
ture of the interviews, the interviewer started
with detailed questions on a topic to obtain
detailed information, followed bymore general
discussions. The general discussion was used to
probe the answers and assess the interviewees’
knowledge of the topic. Multiple interviews
were conducted in individual companies and
institutions. Multiple interviews per company
allowed for real-time company-internal verifica-
tion of the results in two or three interviews,
supporting the validity of the research data.
Interviews in 12 companies, including the main
multinational players, proved sufficient to
probe the salience and role of individual
agglomeration factors.
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THE SPATIAL DISTRIBUTION OF THE
IRISH PHARMACEUTICAL INDUSTRY
Ireland is characterised by a very mono-centric
urban system. Approximately one third of the
state’s population of 4.5million people are con-
centrated in the Dublin Metropolitan Area.
The urban centres in the second tier are far
smaller than Dublin. Cork City is the second
urban centre of the country with a population
of 190,000, followed by Limerick/Shannon,
Galway, Waterford and Dundalk (See
Figure 1). These cities all have important and
varied urban services functions for relatively
large hinterlands.
Table 2 presents the spatial distribution of
employment in the pharmaceutical industry in
Ireland. The overall picture is one of modest
concentration. There are two main concentra-
tions, one in Cork county and one in Dublin
county. In 2003 the two counties accounted for
45 per cent of all employment in the industry.
Outside these two regions there are sizeable
secondary concentrations in four other coun-
ties. Still, a significant number of operations,
accounting for 22 per cent of employment, are
scattered around the country outside these con-
centrations. The simple figures regarding the
spatial distribution of pharmaceutical employ-
ment are reflected in the MS index, often used
Figure 1. Location of drug substance operations, 2003.
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as an indication of the operation of localisation
economies. The value of g for the total pharma-
ceutical industry in 2003 was 0.03, on the low
side in the ‘moderately concentrated’ category.
A more detailed examination of the industry
reveals strongly contrasting spatial patterns for
the two main sub-sectors. The drug substance
or API sub-sector is characterised by a large
grouping of operations in Cork, a secondary
grouping in Dublin and a relatively small
number of isolated operations outside these
two counties (See also Figure 1). County Cork
accounts for nearly half of total employment
while Dublin accounts for another quarter. The
MS index for the sub-sector in 2003 is 0.20,
indicating a very high level of spatial concentra-
tion. In contrast, drug products operations are
far less spatially concentrated. Six counties
each account for between 8 and 19 per cent of
the total and several other counties are active in
this sub-sector. TheMS index computed for the
sub-sector in 2003 is –0.02, indicating a very low
level of spatial concentration.
Figure 2 shows the trends, over time, for the
MS index for all pharmaceutical employment
and for employment in the drug substance and
drug products sub-sectors. The drug substance
sub-sector has been characterised by a high and
rising MS index for most of the period since
1972. After a period characterised by a rela-
tively low MS index during the 1970s, the sub-
sector became ‘very concentrated’ (g > 0.05) by
1980 and for the next two decades the index
shows a rising trend, reaching the very high
value of 0.25 in 2001. Since reaching this peak
the value has dropped somewhat. In contrast,
the drug products sub-sector has always been
characterised by a low level of concentration.
The MS index was very low during the early
1970s. From 1975 the index rose to a peak in
1984, but since then has shown a downward
trend, falling below zero in 1992.
This paper focuses on spatial concentration
and the role of agglomeration economies in
this process. Since the drug products sub-sector
is characterised by very low levels of spatial con-
centration, the remainder of this paper will
focus on the drug substance subsector.
THE SPATIAL DYNAMICS OF THE DRUG
SUBSTANCE SUB SECTOR: CAUSES OF
CONCENTRATION AND THE ROLE OF
AGGLOMERATION ECONOMIES
The high and rising level of spatial concentra-
tion in the drug substance sub-sector might
suggest the operation of agglomeration econo-
mies, notably localisation economies. This
section will investigate the spatial dynamics of
the industry and the determinants for the high
level of spatial concentration. The analysis
identifies the causes for concentration (in Mar-
shall’s terms) and the role of agglomeration
economies.
Table 2. Employment pharmaceutical sector by county (%), 2003.
All pharmaceutical
operationsa
Drug substance
operationsb
Drug product
operationsb
Cork 25 48 8
Dublin 20 26 16
Mayo 10 0 19
Waterford 9 0 17
Wicklow 7 8 5
Kildare 7 0 13
Tipperary 5 7 4
Clare 4 8 0
Roscommon 4 0 8
Other 9 3 10
Ireland 100 100 100
Notes: a Includes drug substance, drug products, non-substance intermediates and diagnostics operations.
b Excluding employment in operations involved in both drug product and drug substance production.
Source: Forfás Employment Survey.
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Spatial dynamics and causes of initial concen-
tration – Table 3 lists the new drug substance
operations established on new sites in the
period up to 1986. Three drug substance plants
were established in the 1960s, all of them in the
Dublin region. However, despite this head
start, the period of rapid growth of drug sub-
stance manufacturing activity in Ireland in the
1970s largely bypassed Dublin. Until the mid-
1970s, in terms of number of operations, the
spatial pattern of the sub-sector was rather dis-
persed. Apart fromDublin and the area around
Cork City, a number of companies had estab-
lished plants on isolated sites in small rural
towns on or near the banks of rivers that were
used to discharge the wastewater. It was only in
the second half of the 1970s that Cork really
started to establish itself as the centre of drug
substance production in Ireland. By the mid-
1980s there were ten drug substance operations
in County Cork. The data on new operations
are reflected in Figure 3, which charts the
changing distribution of employment. Cork’s
share of total drug substance employment rose
from 36 per cent in 1972 to 47 per cent in 1986.
The main ‘causes’ (as defined by Marshall)
for this spatial concentration in Cork are
related to government intervention, notably
environmental regulation, regional policy,
and related investment in serviced industrial
sites. In the early 1970s the IDA identified the
pharmaceuticals industry as one of its target
sectors. Pharmaceutical plants had specific
locational requirements. Pharmaceutical pro-
duction facilities – in particular large drug sub-
stance plants – required sites that were serviced,
to a relatively high specification, with effluent
disposal facilities, fresh water, and electricity. In
general the fresh water requirements far out-
stripped the existing capacities available in
most municipalities (Leonard 1988). In fact,
one of the early movers, Pfizer in Cork
Harbour, needed to drill a series of wells to
augment the public water supply (Clarke et al.
2003).
As part of its strategy, the IDA invested in the
necessary infrastructure, concentrating most of
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Figure 2. MS-index pharmaceutical sub-sectors, 1973–2003.
Table 3. Location of new drug substance operations on new
sites, 1961–2006.
Cork
Harbour
Cork
(other)
Dublin Ireland
(other)
1961–71 0 0 3 0
1972–86 8 2 1 5
1987–2002 2 0 7 3
2003–2006 2 0 1 1
Source: Forfás Employment Survey.
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its limited resources in Cork Harbour, adjacent
to Cork City. In the second half of the 1970s,
the IDA purchased large land banks in the
harbour area, notably at Little Island and Rin-
gaskiddy. It invested in the required drainage
infrastructure, including a major marine
outfall for discharge of effluent in Ringaskiddy.
In addition, during the late 1970s/early 1980s,
Cork County Council created the largest capac-
ity of processed water in the country through
the Harbour and City Water Supply Scheme.
In later years, the Electricity Supply Board
installed the required power supply (Childs
1996).
The rapid build-up of suitable physical
infrastructure and the availability of sizeable
industrial sites, often with outline planning per-
mission already in place, made Cork Harbour a
relatively attractive location (in the context of
Ireland) for new drug substance projects
(Gallagher 2003). In addition, having made
substantial investments, the IDA was eager to
sell the land in Cork Harbour. Whenever a
company was interested in setting up a drug
substance plant in Ireland, the IDA would
strongly promote its sites in Cork Harbour. In
the words of a former national IDA executive:
‘Ringaskiddy became the site if you like. That is
where we wanted people to go’ (see also
Breathnach 1982).
Thus, in the ten-year period between 1975
and 1986, six of the ten new drug substance
operations on new sites in Ireland were estab-
lished in Cork Harbour, and by the mid-1980s,
the area had firmly established itself as the
centre of the pharmaceutical industry in
Ireland. Without the spatial planning driven
actions, the spatial pattern of the industry
would have developed quite differently.
The question remains, as to why the IDA
concentrated so much of its limited resources
in Cork Harbour? One of the main reasons was
regional planning. During the 1960s and early
1970s, spatial and industrial policy became
increasingly characterised by an attempt to
encourage a shift of manufacturing employ-
ment out of Dublin, the traditional core area of
the national economy. The Buchanan Report
(Buchanan and Partners 1968) advocated a
policy of concentrated deconcentration in a
select number of growth centres, notably Cork
and Limerick-Shannon.2 The industrial policy
was to be implemented by the IDA through its
regional industrial plans.
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Figure 3. Share of Cork and Dublin in drug substance employment, 1973–2003.
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Partly in response to this, in 1972 the Cork
Harbour Commissioners, in close co-operation
with the IDA and Cork planning authorities,
proposed the Cork Harbour Development
Plan, involving a major upgrading of the port,
including the development of large industrial
zones. Ringaskiddy was to be specifically devel-
oped for deep-water industries requiring large
volumes of water and adequate facilities for
large-scale effluent disposal (Brunt 1980).
Another reason for concentrating limited
resources in Cork Harbour is related to envi-
ronmental regulations and public concerns,
although Cork Harbour would not have been
the only possible location on the basis of this
factor. Although the standards were still rela-
tively relaxed, by the end of the 1960s, local
governments were starting to drive quite tough
bargains with pharmaceutical plants about the
level of chemical effluent the companies were
allowed to discharge in natural water bodies
(Leonard 1988). For drug substance plants
located on the banks of inland rivers with
limited assimilative capacity,3 this created a
need for intensive on-site treatment of wastewa-
ter. This reduced the relative attractiveness of
such sites, especially in small urban centres with
limited municipal sewage treatment capacity.
On the other hand, it increased the suitability
of locations near tidal rivers, estuaries or the
sea. Large assimilative capacity was one of the
most important location factors for the first two
pharmaceutical companies which located in
Cork Harbour in the early 1970s (Pfizer and
PennChemicals). In fact, it is argued that Pfizer
would probably not have invested in Cork
Harbour at all if it had not been allowed to
discharge untreated wastewater in the Harbour
(Leonard 1988).
In addition, concern among the general
public as well as local and central government
about thepotential pollutioncausedbypharma-
ceutical and other chemical plants rose very
quickly during the 1970s (Leonard 1988). This
was partly driven by severe odour problems
caused by some of the first established drug sub-
stance plants. In response, between 1970 and
1978, the IDA started to carefully select sites that
would minimise the environmental impact of
new pharmaceutical projects. With respect to
wastewater discharge, in principle there were
many suitable locations in Ireland that offered
sufficient assimilative capacity. However, inten-
sifying public concern and stricter planning
regulations made the establishment of isolated
large-scale chemical synthesis plants in rural set-
tings increasingly difficult. In 1978, Eli Lilly was
the last company to get planning permission for
such a development and, given the strong scru-
tinybybothgeneralpublic andplanningbodies,
was fortunate to get it (Leonard 1988). Instead,
the aim was to guide plants that produced large
amounts of effluent into two areas, partly
selected because of their great assimilative
capacity, namely, Cork Harbour and the
Shannon Estuary near Limerick (Leonard
1988). Initially, in the mid-1970s, two new drug
substance plants located in the Shannon area.
However, with the establishment of new, well-
serviced, industrial estates in Cork Harbour in
the second half of the decade, this area became
the prime location for new drug substance
plants.
After the mid-1980s, the geography of the
drugsubstancesub-sectorchangedsignificantly.
The main change has been the rising signifi-
cance of Dublin as a location for drug substance
plants. This change is best captured by the loca-
tion pattern of new drug substance sites estab-
lished between 1987 and 2006 (Table 3). With
eight new drug substance sites, Dublin
accounted for half of such sites in Ireland.
Although Cork Harbour continued to receive
new plants on new sites, it was less successful,
particularly in the 15-year period from 1987–
2003, when it accounted for only two of the 13
new plants established on new sites in Ireland.
These developments are not fully reflected in
the data for investment and employment for
the drug substances sub-sector. This is because
many existing companies made significant
repeat investments in Ireland, generally
expanding on existing sites throughout the
country. As regards the distribution of employ-
ment, it is only in the early 2000s that we see a
significant decrease in Cork’s share (from 56
per cent in 2001 to 49 per cent in 2003) and an
increase in Dublin’s share (from 14 per cent in
2002 to 26 per cent in 2003). The reduction in
Cork’s share is reflected in a reduction of the
MS index (see Figure 2), indicating a lower
level of spatial concentration in the sub-sector.
However, the share of the top two counties
(Cork and Dublin) actually rose from 61 per
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cent in 1986 to 74 per cent in 2003 (see
Figure 3).
The rise of Dublin’s share of total drug
substances employment in Ireland was, once
again, strongly influenced by government
intervention, notably changing regional plan-
ning policies and the related location of new
well-serviced industrial sites. The 1970s policy
of industrial dispersal and encouragement of a
shift of manufacturing employment away from
Dublin was progressively relaxed in the 1980s
(White 2000). This was partly a response to
the fact that, during the 1970s and 1980s, the
East Region (containing Dublin) experienced
serious industrial decline and its share ofmanu-
facturing employment shrank significantly
(Drudy 1991). Thus, during the 1980s and
1990s local authorities, in conjunction with the
IDA, developed a number of well-serviced
industrial estates in County Dublin.
The attraction of such readily-available,
large, well-serviced industrial sites has
increased in the period since the mid-1980s.
Increasingly stringent regulations and controls
are shortening the effective period of patent
protection in the pharmaceutical industry
(Van Egeraat & Breathnach 2012), making
the time it takes to establish a new manufac-
turing plant of strategic importance. In addi-
tion, the fermentation processes used in the
expanding biopharmaceutical sub-sector have
very high utility requirements, particularly
power and wastewater disposal facilities. A
good example of infrastructure influencing
plant location involves the Wyeth Biopharma-
ceuticals plant in Dublin. Initially, the
company considered locating this large biop-
harmaceutical facility near its existing drug
products plant in Newbridge, a mid-size town
some 50km southwest of Dublin. However, the
campus was eventually located in Dublin
because adequate wastewater treatment ser-
vices were not immediately available in New-
bridge (Byrne 2000).
Thus, since 1987 a new concentration of
drug substance plants emerged in Dublin while
the existing concentration in Cork expanded in
absolute terms, particularly since 2003.
The role of agglomeration economies – Let us
now consider to what extent the concentration
of drug substance plants in Cork, and later in
Dublin, was driven by the operation of agglom-
eration economies, and especially localisation
economies, that is, a growing number of
increasingly specialised input suppliers, tech-
nological spillovers and a pooled market for
workers with specialised skills.
As regards specialised input suppliers, if this
were an important factor in the concentration
of drug substance plants in Cork, one would
expect a co-location of buyers and suppliers.
Drug substance plants use a range of material
inputs, but the corporate interviews show that
virtually none of the raw materials used by the
drug substance plants are manufactured in
Dublin or Cork – or Ireland for that matter (see
also Van Egeraat and Barry 2009). Similarly,
none of the interviewed drug substance plants
sell their output to drug product plants in
Ireland. In addition, drug products plants are
strongly under-represented in Cork.
The growth of the pharmaceutical industry
did help to attract a number of process engi-
neering and construction management compa-
nies to both cities in the 1980s and 1990s (see
also Kearny 2003). Most interviewees in Cork
and Dublin perceived this concentration of
engineering companies at their doorstep as
beneficial. However, most of these companies
service a range of other sectors, including other
chemical sectors and food processing. There-
fore, to the extent that the concentration of
engineering companies does present an advan-
tage, it is largely an urbanisation economy. This
could point to a process of agglomeration
involving ‘related variety’ (Asheim et al. 2011)
where, via engineering services, knowledge of
the pharmaceutical sector could have been
transferred to other parts of the regional
economy.
However, it is unlikely that it was a particu-
larly important factor in companies’ decisions
to locate in Cork or Dublin since pharmaceuti-
cal plants in more isolated areas do not experi-
ence notable disadvantage due to distance
from the offices of these service firms. Engi-
neering companies tend to provide efficient
services nationwide. As an interviewee at amore
isolated plant stated: ‘We have no issue with
engineering companies. They are always very
quick’. In a sense, the advantages operate on
the Irish national scale, rather than the local
scale.
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As regards technological spillovers, like most
plants operating in Ireland during the 1970s
and 1980s, the drug substance plants in Cork
had a strong branch-plant character, with
limited functionality other than bulk manufac-
turing. Technology was generally directly trans-
ferred from the strategic plants in the home
countries. Headquarter and product/process
development functions were absent. This
makes it unlikely that there were any techno-
logical externalities embedded in the local
milieu, facilitating processes of learning and
innovation. In spite of noticeable upgrading
since the mid-1980s, the industry has remained
truncated with virtually no R&Dor headquarter
functions. It was only at the late-1990s that a
number of companies started to add late-stage
process development functions to their Irish
operations, while upstream process develop-
ment and discovery functions remain largely
absent.
The interviews provided very little evidence
of genuine technological spillovers operating
via untraded interdependencies and uninten-
tional information exchange and facilitating
innovation within the local industry. There is a
degree of contact between local companies and
local institutions concerning local infrastruc-
ture and production climate in general, notably
in Cork. However, according to the inter-
viewees this contact does not act as a medium
for technological spillovers facilitating innova-
tion within the local industry. Even intentional
interaction regarding technology is limited,
dyadic and often not locally/regionally
bounded. In spite of focused nature of the
interviews, we found very little evidence of tech-
nological interaction between pharma compa-
nies in Ireland, not to mention between
companies in individual clusters. Collaborative
research projects between companies and local
universities have been rare, although there
have been a handful of examples since the
2000s. Even then, some of these projects
involve universities and companies located in
different regions. Even a company with a sub-
stantial process R&D unit in Cork stated: ‘We
have no research collaborations’. A regional
IDA representative considered the extent of
local technological spillovers within the largest
spatial concentration of plants in Ireland (in
Cork) in the following way:
Certainly, from a spatial point of view, it [the
drug substance sector in Cork] is a cluster.
But if you look at the broader definition of a
cluster, as defined in terms of the interac-
tion between the companies, with the
broader environment, a greater level of
interaction with the community . . . I think
there is a long way to go yet before you can
describe it as a full cluster.
Finally, the initial concentration in Cork was
not driven by a market for workers with specia-
lised skills. Most of the pharmaceutical workers
in the 1970s and early 1980s were operatives,
with relatively limited skill-levels and generally
no third-level education.
Most of the pharmaceutical workers at the
time would have been operators. They
would not have been, as they are now, gradu-
ates. It was leaving certificate level and less
than that at the time (Interview IDA repre-
sentative Region Cork).
Plants employed a limited amount of engi-
neers and chemists, but these needed to be
qualified as opposed to specialised. Cork did
provide a number of more general labour-
related advantages. It had an industrial history
and a number of companies employed engi-
neering skills, notably the Ford Motor factory.
In addition, Cork had a well-developed third-
level education infrastructure, including a
school of chemistry. University College Cork
produced mainly lower level, general, degrees
and diplomas, with only one Masters and one
PhD degree in chemistry awarded in 1975
(Higher Education Authority). Finally, as the
second city in Ireland, Cork provided a large
pool of general labour, much of which was
unemployed after significant job losses in the
early 1980s (Brunt 2005). These were undoubt-
edly important attractions for drug substance
plants, as they were for a range of other indus-
tries. However, along with Cork City’s well-
developed urban services, these were mostly
urbanisation, rather than localisation,
economies.
It is difficult to determine the precise
strength of these urbanisation economies
during this period. However, whatever their
size, these urbanisation economies cannot, on
their own, serve as an explanation for the loca-
tion and concentration of drug substance
SPATIAL CONCENTRATION IN THE IRISH PHARMACEUTICAL INDUSTRY 351
© 2013 The Authors
Tijdschrift voor Economische en Sociale Geografie © 2013 Royal Dutch Geographical Society KNAG
plants in Cork, since similar economies were
available in a range of other urban centres.
‘Drug substance plants were able to locate at
other locations without problem’ (Interview
national IDA executive).
Since the mid-1980s, the skill-levels in the
drug-substance plants have risen sharply, partly
due to the introduction of more sophisticated
process technologies. Another reason lies in
the expansion or establishment of new func-
tions, notably quality control/assurance and
the above-mentioned process research and
development, particularly since the end of the
1990s (van Egeraat 2010). Apart from a general
rise in skill levels, a substantial share of the
required skills is also increasingly specialised.
Interviewees invariably stated that the supply of
suitably qualified labour has become an impor-
tant location factor. To an extent, the existing
concentration of drug substance plants in Cork
and Dublin was perceived as an advantage in
this respect, but nearly all interviewees related
the supply of qualified labourmore generally to
the location of third level institutions and the
quality of life in the major urban centres of
Ireland. In relation to the third level institu-
tions, one IDA executive remarked:
All the colleges and universities in the
country are supplying the people who work
in the area. So the pharma sector is a
national industry, particularly for the third-
level institutions. It does not matter which
university, your skill is to the same level.
Asked which role the local technical skills
base had played in its decision to locate in Cork
Harbour, the manager of a plant established
since 1987 replied:
For [our company] it was important that we
had a university at our doorstep, good tech-
nical colleges for want of another word, for
the supply of qualified staff . . . So long as
they have a Regional Technical College it is
okay. It does not have to be in Cork.
We do not have time series data which would
allow us to analyse changes in the relevant
importance of University College Cork (UCC)
in the pharmaceutical-related sciences. What
we can say is that Cork’s graduate output in
these sciences has substantially increased
since the 1970s (Higher Education Authority4).
UCC went from producing only a handful of
biology/biochemistry, chemistry and com-
bined life-science Masters (9) and PhD (2)
degree graduates in 1974/75 to a far more sub-
stantial output in 2005/06 (41 Masters and 46
PhDs). However, UCC is not the sole (and not
even the largest) producer of pharmaceutical-
related post-graduates in Ireland. For example,
the output of these post-graduate qualifications
in the Great Dublin area (79 Masters and 143
PhDs) well surpasses that of UCC.
The interviews also show that most compa-
nies now have some interaction with local third-
level institutions regarding course content.
This interaction has had a positive influence on
the numbers and specific skills of local gradu-
ates. For example, the course content of a
recently established BPharm/BSc Pharm
degree in UCC was to some extent influenced
by the specific needs of the pharmaceutical
industry and facilitated by discussions with staff
of local pharmaceutical companies (Barron
2007). That said, the companies have had
contact with non-local universities and some of
the companies are represented in national-
level forums, influencing the skill levels in
Ireland as a whole.
As regards quality of life, interviewees noted
that qualified and specialised labour is very
mobile and most companies recruit on a
national and international basis. The targeted
highly qualified people tend to have relatively
high expectations regarding availability of ser-
vices, which often translates in a preference for
a location in or near the major population
centres (see also Malecki 1979).
From the staff point of view, there is a trend
that the higher educated people have higher
expectations regarding services. That quality
of service is only found in the major popula-
tion centres. So Dublin, Cork, Waterford,
Galway, Limerick are the primary locations
(Interview manager drug substance plant).
For both reasons companies prefer locations
in or near these centres. At least two plants that
were located further away from the main urban
centres in Ireland have experienced greater
difficulties attracting qualified staff and one
general manager stated that he would not
locate in a similar area again for this reason. ‘It
has been difficult to attract people that want to
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live here. At times we would have a position
open for six months, or even a year’ (Interview
personnel manager drug substance plant). A
number of interviewees believed that the attrac-
tiveness of Dublin is since the 2000s being offset
by the rising house prices and cost of living in
that city. It was believed that this was starting to
have a deterring effect on investments in
Dublin and may be one of the reasons behind
the recent resurgence of investment in Cork
harbour.
Thus, without completely dismissing the
recent emergence of limited localisation
economies, to the extent that drug substance
plants were attracted to Dublin and Cork
because of the location of third-level institu-
tions and the quality of life that the two cities
offered as major population centres, the
market for qualified and specialised workers
should again be interpreted mainly as an
urbanisation economy. Again, these kinds of
urbanisation economies were available in other
urban centres as well. In this respect, other
suitable urban centres mentioned during the
interviews included Galway, Limerick, and
Waterford. Thus, although both factors prob-
ably confer advantages onDublin andCork, it is
questionable whether they represent an impor-
tant part of the explanation for the concentra-
tion of the sub-sector in these particular cities.
As regards the future, interviewees at seven
drug substance plants were asked to identify the
three most important locational considerations
if they currently had to decide on a location
within Ireland. Two factors stood out in the
replies. All interviewees regarded the availabil-
ity of skills as an important factor. This factor
was generally mentioned in conjunction with
the proximity to a third-level institute. Five
interviewees also mentioned the importance of
well-serviced sites and utilities. This factor was
less important for the two other plants because
of their relatively small scale of operations.
Given the fact that there are several urban
centres that can satisfy the skills requirement,
the factor that is likely to most strongly influ-
ence the location of drug substance plants, and
their possible concentration in certain areas,
therefore, is the availability of well-serviced
sites. A former IDA executive expressed this as
follows: ‘They [the drug substance plants] look
at Ireland for the tax, and they look for the
availability of a site that would suit them, and
then they check to see what the skills are like’.
In support of this contention, a senior manager
of a recently-established large-scale drug sub-
stance plant remarked:
I would say the infrastructural issues are
most important because, you know, we have
a big facility . . . If you can’t support the
facility you have a major problem. Obviously
the skills base then would be a significant
additional factor . . . With the caveat that you
could meet these requirements, mainly the
infrastructural ones . . . there is no reason
why you could not locate in some of these
other centres [other thanDublin and Cork].
But again, with the caveat of meeting all of
the infrastructural requirements, mainly
utilities.
Regional planning policies and the concomi-
tant investment in industrial sites and infra-
structure are therefore likely to play an
important role in the future spatial distribution
of the sub-sector. In this respect the National
Spatial Strategy (NSS) 2002–20 (Government
of Ireland 2002) will play an important role. It
aims to achieve a greater balance of socio-
economic growth between regions, partly
through the concentration of development in
nine national ‘gateway’ centres of critical mass.
The IDA has embraced the NSS (see Dorgan
2004) and supports it via its FDI promotion
strategy, including the distribution of ‘strategic
sites’ (see also O’Kane 2005). This is a specific
category of IDA sites developed to support
large and medium-scale manufacturing activi-
ties with large utility requirements, especially
pharmaceutical plants. Apart from Ringaskiddy
(in Cork Harbour) and Dublin, the newer stra-
tegic sites are all located in the vicinity of
coastal ‘gateways’: Galway, Dundalk, Limerick/
Shannon and Waterford (See Figure 1). The
completion of the strategic site in Waterford
was promptly followed by Servier’s decision in
2006 to establish a large scale bulk active ingre-
dients plant on the site. These developments
are likely to lead to a reduction of the high
levels of spatial concentration on a national
scale.
Environmental and regional planning policy
and the related spatially selective provision of
infrastructureclearlyhavebeen,andcontinueto
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be, the most important influence on the spatial
configurationof the Irishpharmaceutical indus-
try, including on the continued growth of the
Cork and Dublin concentrations. Although
some localisation economies have emerged,
these remain relatively limited and their role in
shaping industrial concentrations remains at a
much lower order ofmagnitude. The important
role of environmental and regional planning
policy reflects, of course, the specific character-
istics of the drug-substance sub-sector, charac-
terised by large-scale plants with high
infrastructure and utility requirements. As illus-
trated in this paper, the lower utility require-
ment and relatively limited environmental
impactof thedrugproducts sub-sectorhas led to
a dispersed spatial pattern. The consequences
of these findings for the debate concerning
the potential transformation of satellite
industrial platform-type concentrations to self-
perpetuating concentrations, will be discussed
in the conclusion.
CONCLUSION
This paper has explored the idea that spatial
planning-driven satellite industrial platform
concentrations may, over time, automatically
gain the capacity to generate substantial
agglomeration economies and ultimately trans-
form into entities capable of stimulating self-
perpetuating growth associated with advanced
satellite industrial districts or pioneering high
technology districts. This idea has been
explored in the context of the spatial dynamics
of the pharmaceutical industry in Ireland,
notably the drug substance sub-sector.
The drug substance sub-sector in Ireland has
been spatially concentrated since the 1970s,
when Cork Harbour established itself as by far
the single most important centre of drug sub-
stance manufacturing in Ireland. The period
since themid-1980s has been characterised by a
relative shift to Dublin, although the drug sub-
stance sub-sector in Cork has continued to
expand.
We have shown how the high level of concen-
tration of the drug substance sub-sector in the
two particular urban centres has largely been
driven by regional spatial planning policy and
the related spatially selective provision of well-
serviced industrial sites and infrastructure. The
Cork concentration, even after forty years of
existence, has not generated substantial
agglomeration economies and has not trans-
formed into an entity capable of stimulating
self-perpetuating growth of the type associated
with advanced satellite, or pioneering
high technology, industrial districts. Spatial
planning-type government intervention, rather
than agglomeration economies, remains the
most important driver for growth.
This is not to say that companies in the two
locations do not benefit from agglomeration
economies at all. Certain types of agglomera-
tion economies have spontaneously arisen, par-
ticularly since the mid-1980s. However, their
role in shaping local industrial concentration
remains at a much lower order of magnitude
than that of government spatial planning and
related environmental legislation. They are
mainly of the urbanisation type, relating par-
ticularly to the pooled market for workers and,
to a lesser extent, input suppliers (engineering
services). Limited localisation economies have
recently been developing in the form of the
supply of specialised qualified labour. The
research found no evidence of genuine tech-
nological spillovers. Although urbanisation
economies have been a factor in the concentra-
tion of the industry near the two urban centres,
the fact that these economies have also been
available in several other urban centres means
that they cannot serve as an explanation for the
particular concentration of the drug substance
plants in Cork and Dublin.
The limited role of localisation economies is
partly underlined by the development of the
second concentration of drug substance plants
in Dublin since the mid-1980s. Under a
changed spatial planning regime, the provision
of suitable sites and utilities in Dublin insti-
gated a substantial shift in the location of new
drug substance plants. Further support for the
relatively limited influence of localisation
economies is found in recent investments on
IDA strategic sites near urban centres other
than Dublin and Cork, again driven by spatial
planning considerations.
The findings of this case study of the Irish
pharmaceutical industry cannot simply be gen-
eralised to all other cases of spatial planning
driven industrial platforms. Developments may
depend on the specific knowledge base
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involved (Asheim et al. 2011). The pharmaceu-
tical industry has distinct functional require-
ments along the value chain, with a relatively
high level of analytical knowledge. Industrial
development might be different in contexts
where synthetic (Moodysson et al. 2008) or sym-
bolic knowledge bases dominate (Van Egeraat
et al., 2013). Spatial planning driven platforms
based on foreign direct investment are not con-
fined to industries characterised by analytical
knowledge based industries.
But the findings do reiterate the need to
differentiate between different types of indus-
trial concentrations. The evidence presented in
this paper does not challenge the large body of
work that demonstrates the salience of localisa-
tion economies, notably technological spill-
overs, in the process of spatial concentration in
general. Existing studies of the global ‘mega-
centres’ of the pharmaceutical industry in core
economies such as the USA and the United
Kingdom show that localisation economies,
notably technological spillovers, have played an
important role in the process of spatial concen-
tration (e.g. Schreuder 1998; Boasson and
MacPherson 2001; Cooke 2003). However, the
case of the Irish pharmaceutical industry serves
to show that the kind of spatial planning-driven
satellite industrial platforms in the context of
late-developing countries do not automatically
start generating substantial localisation econo-
mies and crucial technological spillovers, not
even in the largest concentration worldwide
after nearly 40 years of existence. In the context
of underdeveloped research infrastructures
and low levels of entrepreneurship, a transfor-
mation into self-perpetuating industrial con-
centrations will require more than spatial
planning policy.
Such a transformation, notably the develop-
ment of technological spillovers, requires the
truncated branch plants to become involved in
more substantial innovate activities, as well as
the development of an indigenous segment
with sufficient absorptive capacity. This will
require a more comprehensive innovation and
industrial policy that supports investment in
R&D, development of the science-base and the
functioning of innovation system, and is gener-
allymore sensitive to the role of institutions and
the path dependent nature of spatial concen-
tration and innovation processes (Menzel et al.
2010). Such policies would better position
Ireland to take full advantage of the current
strategy of pharmaceutical companies to inter-
nationalise their core R&D functions and, at
the same time, would support the development
of an indigenous segment.
Transforming the pharmaceutical concen-
trations in Ireland into self-perpetuating phar-
maceutical innovation arenas will require a
greater focus on the development of indig-
enous innovation capacity, both in the form of
university departments and research institutes.
This includes policies supporting entrepre-
neurship, spin-off formation and the availabil-
ity of venture capital (Carlsson 2006; Orsenigo
2006). The Strategy for Science Technology
and Innovation (DETE 2006) and the more
recent ‘Smart Economy’ document launched
by the Irish Government (Government of
Ireland 2008) include many elements that will
support such a development over time.
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Notes
1. The Herfindahl index is a measure of industry
concentration, generally used as an indicator of
competition among firms. It is defined as the sum
of the squares of the market shares of each indi-
vidual firm. It can range from 0 (a very large
amount of small firms) to 1 (a single firm).
2. Subsequent official policy statements emphasised
a greater dispersal of development throughout
the country (Drudy 1991) but Cork remained a
focus for industrial development.
3. Assimilative capacity is the capacity of a natural
body of water to receive wastewaters or toxic mate-
rials without deleterious effects.
4. www.hea.ie. Data for UCC 1974/75 were specially
compiled by the HEA from archive material. The
Greater Dublin universities category comprises of
Trinity College Dublin, University College
Dublin, Dublin City University, and National Uni-
versity of Ireland Maynooth.
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